Advanced glycation endproducts accelerate calcification in microvascular pericytes.

Vascular calcification in advanced atherosclerosis is frequently associated with diabetes, and is a predictor of future cardiovascular events. To investigate the molecular mechanisms of vascular calcification, we examined whether advanced glycation endproducts (AGE) formed at an accelerated rate under diabetes induce the osteoblastic differentiation of pericytes, a mesenchymal progenitor. First, von Kossa staining demonstrated that AGE significantly increased the number of calcified nodules in a bovine pericyte culture. AGE were also found to induce calcium accumulation in the pericyte monolayer in time- and dose-dependent manners. Second, quantitative reverse transcription-polymerase chain reaction revealed that AGE increased the pericyte levels of mRNAs coding for alkaline phosphatase and osteopontin, the representative markers for early and late osteoblastic differentiation, respectively. Alkaline phosphatase activity was actually enhanced by AGE. The results suggest that AGE have the ability to induce the osteoblatic differentiation of pericytes, which would contribute to the development of vascular calcification in diabetes.

[1]  Hiroshi Yamamoto,et al.  Advanced glycation endproducts inhibit prostacyclin production and induce plasminogen activator inhibitor-1 in human microvascular endothelial cells , 1998, Diabetologia.

[2]  Hiroshi Yamamoto,et al.  Advanced Glycation End Products-driven Angiogenesis in Vitro , 1997, The Journal of Biological Chemistry.

[3]  H. Vlassara.  Advanced glycation end-products and atherosclerosis. , 1996, Annals of medicine.

[4]  Hiroshi Yamamoto,et al.  Advanced glycosylation end products stimulate the growth but inhibit the prostacyclin‐producing ability of endothelial cells through interactions with their receptors , 1996, FEBS letters.

[5]  Yasuhiko Hayashi,et al.  Possible Participation of Autocrine and Paracrine Vascular Endothelial Growth Factors in Hypoxia-induced Proliferation of Endothelial Cells and Pericytes (*) , 1995, The Journal of Biological Chemistry.

[6]  H. Yamamoto,et al.  Receptor-mediated toxicity to pericytes of advanced glycosylation end products: a possible mechanism of pericyte loss in diabetic microangiopathy. , 1995, Biochemical and biophysical research communications.

[7]  R. Detrano,et al.  Prevalence of fluoroscopic coronary calcific deposits in high-risk asymptomatic persons. , 1994, American heart journal.

[8]  H. Yamamoto,et al.  Endothelin 1 mediates endothelial cell-dependent proliferation of vascular pericytes. , 1993, Biochemical and biophysical research communications.

[9]  H. Yamamoto,et al.  Vascular pericytes not only regulate growth, but also preserve prostacyclin-producing ability and protect against lipid peroxide-induced injury of co-cultured endothelial cells. , 1993, Biochemical and biophysical research communications.

[10]  M. Young,et al.  The cDNA cloning and RNA distribution of bovine osteopontin. , 1991, Gene.

[11]  A. Barger,et al.  Hypothesis: vasa vasorum and neovascularization of human coronary arteries. A possible role in the pathophysiology of atherosclerosis. , 1984, The New England journal of medicine.

[12]  G. Stein,et al.  The onset and progression of osteoblast differentiation is functionally related to cellular proliferation. , 1989, Connective tissue research.

[13]  S. Udenfriend,et al.  Cloning and sequencing of bovine kidney alkaline phosphatase cDNA. , 1987, Gene.